Now detect tumours with radiation-free scanning technique

Scientists have developed a new technique to scan young cancer patients' bodies for tumours without exposing them to radiation.

The technique could reduce patients' risk of developing secondary cancers later in life, 

researchers said. The new method developed by researchers from the Stanford 

University Medical Center and Lucile Packard Children's Hospital Stanford is a 

modification of magnetic resonance imaging that employs a novel contrast agent to find 

tumours. Researchers found that the MRI-based method is as effective as cancer-

detection scans that use ionising radiation - specifically, positron emission tomography-

computed tomography. Although whole-body PET-CT technology provides essential 

information for detecting cancer, it has one big drawback: A single scan exposes the 

patient to as much radiation as 700 chest X-rays. This exposure is especially risky for 

children and teenagers, who are more vulnerable to radiation than adults because they 

are still growing. Children are also more likely to live long enough to develop a second 

cancer. "I'm excited about having an imaging test for cancer patients that requires zero 

radiation exposure," said senior author Heike Daldrup-Link, associate professor of 

radiology at Stanford and a diagnostic radiologist at the hospital. The research team 

compared the modified MRI technique to standard PET-CTs in 22 patients ages 8 to 33 

who had lymphoma or sarcoma. These cancers originate in the immune system and the 

bones, respectively. Both cancers can spread throughout tissues such as bone marrow, 

lymph nodes, liver and spleen. In the past, several hurdles prevented physicians from 

using whole-body MRIs to look for tumours. The scans take up to two hours. A whole-

body PET-CT takes only a few minutes. More importantly, in many organs, MRI does not 

distinguish healthy from cancerous tissue. And existing contrast agents - chemicals 

injected into the body to make tumours visible - leave the tissues too quickly to be used in 

a lengthy, whole-body MRI. To find tumours via MRI, the Stanford team used a new 

contrast agent consisting of nanoparticles of iron. Injections of these iron nanoparticles 

are approved by the US Food and Drug Administration to treat anemia, and the 

researchers obtained FDA permission for the experimental use. The nanoparticles are 

retained in the body for many days. On MRIs, they cause blood vessels to appear 

brighter, providing anatomic landmarks. The nanoparticles also cause healthy bone 

marrow, lymph nodes, liver and spleen to appear darker, making tumours stand out. The 

PET-CTs detected 163 of 174 total tumours in the 22 patients; the MRIs found 158 of 174 

tumours, researchers said. 

The study was published in The Lancet Oncology.

ps- this is only for information, always consult you physician before having any particular food/ medication/exercise/other remedies.

ps- those interested in recipes are free to view my blog-

http://gseasyrecipes.blogspot.com/

for info about knee replacement, you can view my blog-

http://Knee replacement-stick club.blogspot.com/

for crochet designs

http://My Crochet Creations.blogspot.com